BioNTech SE (BNTX) (Q3 2026) Earnings Call Highlights: Oncology Pipeline Momentum Builds as ...
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- BNTX BioNTech SE-9.2% 9d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that BioNTech SE belongs to, so it often moves with news about it.
- NBIX Neurocrine Biosciences+16.5% 9d
Neurocrine Biosciences is a peer of BioNTech SE in biological products, (no diagnostic substances); rivals often move on the same news.
- QGEN Qiagen N.V
Qiagen N.V is a peer of BioNTech SE in biological products, (no diagnostic substances); rivals often move on the same news.
- CRSP CRISPR Therapeutics AG-23.0% 30d
CRISPR Therapeutics AG is a peer of BioNTech SE in biological products, (no diagnostic substances); rivals often move on the same news.
- AMGN Amgen+15.9% 30d
Amgen is a peer of BioNTech SE in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+16.4% 30d
Gilead Sciences is a peer of BioNTech SE in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| BNTX | +1.32% | +1.48% | base | +4.41% | -1.16% | +0.80% | +0.74% |
| XLV | -2.31% | +0.48% | base | +3.08% | +0.65% | +0.47% | +2.39% |
| NBIX | -11.66% | -11.28% | base | +0.80% | -2.96% | -0.05% | +2.49% |
| QGEN | -0.09% | -0.33% | base | +0.85% | +0.94% | -0.13% | +0.31% |
| CRSP | +8.14% | +2.77% | base | +3.56% | -2.95% | +0.14% | +0.08% |
| AMGN | -2.03% | +1.07% | base | +3.67% | -0.14% | +0.04% | +0.88% |
| GILD | -4.93% | +2.07% | base | +4.16% | +0.01% | +0.06% | +1.13% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
BioNTech SE (BNTX) (Q3 2026) Earnings Call Highlights: Oncology Pipeline Momentum Builds as ... Yahoo Finance
Source: Yahoo Finance
Energy
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | that day | +3.67% | final price |
| AMGN | the next day | -0.14% | final price |
| AMGN | two days later | +0.04% | final price |
| AMGN | three days later | +0.88% | final price |
| AMGN | three days earlier | +1.07% | final price |
| AMGN | five days earlier | -2.03% | final price |
| BNTX | that day | +4.41% | final price |
| BNTX | the next day | -1.16% | final price |
| BNTX | two days later | +0.80% | final price |
| BNTX | three days later | +0.74% | final price |
| BNTX | three days earlier | +1.48% | final price |
| BNTX | five days earlier | +1.32% | final price |
| CRSP | that day | +3.56% | final price |
| CRSP | the next day | -2.95% | final price |
| CRSP | two days later | +0.14% | final price |
| CRSP | three days later | +0.08% | final price |
| CRSP | three days earlier | +2.77% | final price |
| CRSP | five days earlier | +8.14% | final price |
| GILD | that day | +4.16% | final price |
| GILD | the next day | +0.01% | final price |
| GILD | two days later | +0.06% | final price |
| GILD | three days later | +1.13% | final price |
| GILD | three days earlier | +2.07% | final price |
| GILD | five days earlier | -4.93% | final price |
| NBIX | that day | +0.80% | final price |
| NBIX | the next day | -2.96% | final price |
| NBIX | two days later | -0.05% | final price |
| NBIX | three days later | +2.49% | final price |
| NBIX | three days earlier | -11.28% | final price |
| NBIX | five days earlier | -11.66% | final price |
| QGEN | that day | +0.85% | final price |
| QGEN | the next day | +0.94% | final price |
| QGEN | two days later | -0.13% | final price |
| QGEN | three days later | +0.31% | final price |
| QGEN | three days earlier | -0.33% | final price |
| QGEN | five days earlier | -0.09% | final price |
| XLV | that day | +3.08% | final price |
| XLV | the next day | +0.65% | final price |
| XLV | two days later | +0.47% | final price |
| XLV | three days later | +2.39% | final price |
| XLV | three days earlier | +0.48% | final price |
| XLV | five days earlier | -2.31% | final price |
Congressional trades in the stocks in this story
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 20 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 43 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 70 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 86 days before publication. Filed 4 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid the energy case looks
12 out of 100
“BioNTech SE (BNTX) (Q3 2026) Earnings Call Highlights: Oncology Pipeline Momentum Builds as ...” scores 12 out of 100. The score uses 1 sources.